2型糖尿病与钙化性主动脉瓣疾病的中介变量分析
Analysis of Mediator Variables of Type 2 Diabetes and Calcific Aortic Valve Disease
DOI: 10.12677/acm.2025.1551637, PDF,   
作者: 刘晓静*：青岛大学附属医院内分泌科，山东 青岛；巩京帅：青岛大学附属医院西海岸院区心脏大血管外科，山东 青岛
关键词: 糖尿病；钙化性主动脉瓣疾病；高血压；甘油三酯葡萄糖指数；中介效应分析；Diabetes Mellitus； Calcific Aortic Valve Disease； Hypertension； Triglyceride-Glucose Index； Analysis of Mediation Effects
摘要: 本研究探讨在T2DM与CAVD的关系中体重指数、高血压、慢性肾脏病、甘油三酯葡萄糖指数、总胆固醇/高密度脂蛋白比值、中性粒细胞/淋巴细胞比值的中介作用。纳入2018年1月至2022年12月青岛大学附属医院心脏大血管外科和健康体检中心的患者数据，采用因果中介效应分析方法，探讨T2DM与CAVD的中介变量。共纳入3979名参与者，CAVD组1925人，非CAVD组2054人。高血压、甘油三酯葡萄糖指数、总胆固醇/高密度脂蛋白比值、中性粒细胞/淋巴细胞比值、慢性肾脏病的中介效应分别为0.114、0.042、0.029、0.015、0.006 (P均<0.001)。高血压的中介效应最大，其次是甘油三酯葡萄糖指数。在糖尿病患者中，强化管理血压、血糖和血脂可降低CAVD风险。
Abstract: This study aims to investigate the mediating effects of body mass index, hypertension, chronic kidney disease, triglyceride-glucose index, total cholesterol/high-density lipoprotein ratio, and neutrophil-to-lymphocyte ratio in the relationship between type 2 diabetes mellitus (T2DM) and calcific aortic valve disease (CAVD). Data from patients at the Department of Cardiothoracic Surgery and the Health Examination Center of Qingdao University Affiliated Hospital between January 2018 and December 2022 were included. Causal mediation analysis was used to explore the mediating variables in the association between T2DM and CAVD. A total of 3979 participants were included, with 1925 in the CAVD group and 2054 in the non-CAVD group. The mediating effects of hypertension, triglyceride-glucose index, total cholesterol/high-density lipoprotein ratio, neutrophil-to-lymphocyte ratio, and chronic kidney disease were 0.114, 0.042, 0.029, 0.015, and 0.006, respectively (all P < 0.001). Hypertension had the largest mediating effect, followed by the triglyceride-glucose index. Based on these findings, intensive management of blood pressure, blood glucose, and blood lipids in diabetic patients may reduce the risk of CAVD.
文章引用：刘晓静, 巩京帅. 2型糖尿病与钙化性主动脉瓣疾病的中介变量分析[J]. 临床医学进展, 2025, 15(5): 2438-2453. https://doi.org/10.12677/acm.2025.1551637

参考文献

[1] Goody, P.R., Hosen, M.R., Christmann, D., Niepmann, S.T., Zietzer, A., Adam, M., et al. (2020) Aortic Valve Stenosis: From Basic Mechanisms to Novel Therapeutic Targets. Arteriosclerosis, Thrombosis, and Vascular Biology, 40, 885-900. [Google Scholar] [CrossRef] [PubMed]
[2] Yadgir, S., Johnson, C.O., Aboyans, V., Adebayo, O.M., Adedoyin, R.A., Afarideh, M., et al. (2020) Global, Regional, and National Burden of Calcific Aortic Valve and Degenerative Mitral Valve Diseases, 1990-2017. Circulation, 141, 1670-1680. [Google Scholar] [CrossRef] [PubMed]
[3] DesJardin, J.T., Chikwe, J., Hahn, R.T., Hung, J.W. and Delling, F.N. (2022) Sex Differences and Similarities in Valvular Heart Disease. Circulation Research, 130, 455-473. [Google Scholar] [CrossRef] [PubMed]
[4] Moncla, L.M., Briend, M., Bossé, Y. and Mathieu, P. (2023) Calcific Aortic Valve Disease: Mechanisms, Prevention and Treatment. Nature Reviews Cardiology, 20, 546-559. [Google Scholar] [CrossRef] [PubMed]
[5] Yu, G., Gong, X., Xu, Y., Sun, H., Liu, Y., Zhai, C., et al. (2023) The Global Burden and Trends of Four Major Types of Heart Disease, 1990-2019: A Systematic Analysis for the Global Burden of Disease Study 2019. Public Health, 220, 1-9. [Google Scholar] [CrossRef] [PubMed]
[6] Otto, C.M. and Prendergast, B. (2014) Aortic-Valve Stenosis—From Patients at Risk to Severe Valve Obstruction. New England Journal of Medicine, 371, 744-756. [Google Scholar] [CrossRef] [PubMed]
[7] Rajamannan, N.M., Evans, F.J., Aikawa, E., Grande-Allen, K.J., Demer, L.L., Heistad, D.D., et al. (2011) Calcific Aortic Valve Disease: Not Simply a Degenerative Process: A Review and Agenda for Research from the National Heart and Lung and Blood Institute Aortic Stenosis Working Group: Executive Summary: Calcific Aortic Valve Disease—2011 Update. Circulation, 124, 1783-1791. [Google Scholar] [CrossRef] [PubMed]
[8] Abdul-Rahman, T., Lizano-Jubert, I., Garg, N., Talukder, S., Lopez, P.P., Awuah, W.A., et al. (2023) The Common Pathobiology between Coronary Artery Disease and Calcific Aortic Stenosis: Evidence and Clinical Implications. Progress in Cardiovascular Diseases, 79, 89-99. [Google Scholar] [CrossRef] [PubMed]
[9] Hsuan, C., Teng, S.I.F., Hsu, C., Liao, D., Chang, A.J., Lee, H., et al. (2023) Emerging Therapy for Diabetic Cardiomyopathy: From Molecular Mechanism to Clinical Practice. Biomedicines, 11, Article 662. [Google Scholar] [CrossRef] [PubMed]
[10] Chen, Y., Xiao, F. and Wang, R. (2022) Calcified Aortic Valve Disease Complicated with and without Diabetes Mellitus: The Underlying Pathogenesis. Reviews in Cardiovascular Medicine, 23, Article 7. [Google Scholar] [CrossRef] [PubMed]
[11] Kaur, R., Kaur, M. and Singh, J. (2018) Endothelial Dysfunction and Platelet Hyperactivity in Type 2 Diabetes Mellitus: Molecular Insights and Therapeutic Strategies. Cardiovascular Diabetology, 17, Article No. 121. [Google Scholar] [CrossRef] [PubMed]
[12] Kozakova, M., Morizzo, C., Goncalves, I., Natali, A., Nilsson, J. and Palombo, C. (2019) Cardiovascular Organ Damage in Type 2 Diabetes Mellitus: The Role of Lipids and Inflammation. Cardiovascular Diabetology, 18, Article No. 61. [Google Scholar] [CrossRef] [PubMed]
[13] Raddatz, M.A., Madhur, M.S. and Merryman, W.D. (2019) Adaptive Immune Cells in CALCIFIC aortic Valve Disease. American Journal of Physiology-Heart and Circulatory Physiology, 317, H141-H155. [Google Scholar] [CrossRef] [PubMed]
[14] Driscoll, K., Cruz, A.D. and Butcher, J.T. (2021) Inflammatory and Biomechanical Drivers of Endothelial-Interstitial Interactions in Calcific Aortic Valve Disease. Circulation Research, 128, 1344-1370. [Google Scholar] [CrossRef] [PubMed]
[15] Manduteanu, I., Simionescu, D., Simionescu, A. and Simionescu, M. (2021) Aortic Valve Disease in Diabetes: Molecular Mechanisms and Novel Therapies. Journal of Cellular and Molecular Medicine, 25, 9483-9495. [Google Scholar] [CrossRef] [PubMed]
[16] Thaden, J.J., Nkomo, V.T. and Enriquez-Sarano, M. (2014) The Global Burden of Aortic Stenosis. Progress in Cardiovascular Diseases, 56, 565-571. [Google Scholar] [CrossRef] [PubMed]
[17] Corrigendum to: Training, Competence, and Quality Improvement in Echocardiography: The European Association of Cardiovascular Imaging Recommendations: Update 2020. European Heart Journal-Cardiovascular Imaging, 22, 187.[CrossRef] [PubMed]
[18] Otto, C.M., Nishimura, R.A., Bonow, R.O., Carabello, B.A., Erwin, J.P., Gentile, F., et al. (2020) 2020 ACC/AHA Guideline for the Management of Patients with Valvular Heart Disease: Executive Summary: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation, 143, e35-e71. [Google Scholar] [CrossRef] [PubMed]
[19] Vahanian, A., Beyersdorf, F., Praz, F., Milojevic, M., Baldus, S., Bauersachs, J., et al. (2021) 2021 ESC/EACTS Guidelines for the Management of Valvular Heart Disease: Developed by the Task Force for the management of valvular heart disease of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS). European Heart Journal, 43, 561-632. [Google Scholar] [CrossRef] [PubMed]
[20] Chambers, J.B., Garbi, M., Nieman, K., Myerson, S., Pierard, L.A., Habib, G., et al. (2017) Appropriateness Criteria for the Use of Cardiovascular Imaging in Heart Valve Disease in Adults: A European Association of Cardiovascular Imaging Report of Literature Review and Current Practice. European Heart Journal-Cardiovascular Imaging, 18, 489-498. [Google Scholar] [CrossRef] [PubMed]
[21] American Diabetes Association Professional Practice Committee (2021) 2. Classification and Diagnosis of Diabetes:standards of Medical Care in Diabetes-2022. Diabetes Care, 45, S17-S38. [Google Scholar] [CrossRef] [PubMed]
[22] Whelton, P.K., Carey, R.M., Aronow, W.S., Casey, D.E., Collins, K.J., Dennison Himmelfarb, C., et al. (2018) 2017 Acc/AHA/AAPA/ABC/ACPM/AGS/APHA/ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Hypertension, 71, 1269-1324. [Google Scholar] [CrossRef] [PubMed]
[23] See, E.J. and Cullen, V. (2024) Commentary on the 2021 Update of the KDIGO Clinical Practice Guideline for Management of Blood Pressure in Chronic Kidney Disease. Nephrology, 30, e14414. [Google Scholar] [CrossRef] [PubMed]
[24] Inker, L.A., Schmid, C.H., Tighiouart, H., Eckfeldt, J.H., Feldman, H.I., Greene, T., et al. (2012) Estimating Glomerular Filtration Rate from Serum Creatinine and Cystatin C. New England Journal of Medicine, 367, 20-29. [Google Scholar] [CrossRef] [PubMed]
[25] Liu, X., Tan, Z., Huang, Y., Zhao, H., Liu, M., Yu, P., et al. (2022) Relationship between the Triglyceride-Glucose Index and Risk of Cardiovascular Diseases and Mortality in the General Population: A Systematic Review and Meta-Analysis. Cardiovascular Diabetology, 21, Article No. 124. [Google Scholar] [CrossRef] [PubMed]
[26] Sud, K., Narula, N., Aikawa, E., Arbustini, E., Pibarot, P., Merlini, G., et al. (2023) The Contribution of Amyloid Deposition in the Aortic Valve to Calcification and Aortic Stenosis. Nature Reviews Cardiology, 20, 418-428. [Google Scholar] [CrossRef] [PubMed]
[27] Shu, L., Yuan, Z., Li, F. and Cai, Z. (2023) Oxidative Stress and Valvular Endothelial Cells in Aortic Valve Calcification. Biomedicine & Pharmacotherapy, 163, Article 114775. [Google Scholar] [CrossRef] [PubMed]
[28] Liu, X., Li, T., Sun, J. and Wang, Z. (2023) The Role of Endoplasmic Reticulum Stress in Calcific Aortic Valve Disease. Canadian Journal of Cardiology, 39, 1571-1580. [Google Scholar] [CrossRef] [PubMed]
[29] Yan, A.T., Koh, M., Chan, K.K., Guo, H., Alter, D.A., Austin, P.C., et al. (2017) Association between Cardiovascular Risk Factors and Aortic Stenosis: The CANHEART Aortic Stenosis Study. Journal of the American College of Cardiology, 69, 1523-1532. [Google Scholar] [CrossRef] [PubMed]
[30] Mosch, J., Gleissner, C.A., Body, S., et al. (2017) Histopathological Assessment of Calcification and Inflammation of Calcific Aortic Valves from Patients with and without Diabetes Mellitus. Histol Histopathol, 32, 293-306.
[31] Yutzey, K.E., Demer, L.L., Body, S.C., Huggins, G.S., Towler, D.A., Giachelli, C.M., et al. (2014) Calcific Aortic Valve Disease: A Consensus Summary from the Alliance of Investigators on Calcific Aortic Valve Disease. Arteriosclerosis, Thrombosis, and Vascular Biology, 34, 2387-2393. [Google Scholar] [CrossRef] [PubMed]
[32] Davicevic, Z., Tavciovski, D. and Matunovic, R. (2010) Medical Treatments in Aortic Stenosis: Role of Statins and Angiotensin-Converting Enzyme Inhibitors. Medicinski pregled, 63, 82-85. [Google Scholar] [CrossRef] [PubMed]
[33] O’Brien, K.D., Probstfield, J.L., Caulfield, M.T., Nasir, K., Takasu, J., Shavelle, D.M., et al. (2005) Angiotensin-Converting Enzyme Inhibitors and Change in Aortic Valve Calcium. Archives of Internal Medicine, 165, 858-862. [Google Scholar] [CrossRef] [PubMed]
[34] Jia, G. and Sowers, J.R. (2021) Hypertension in Diabetes: An Update of Basic Mechanisms and Clinical Disease. Hypertension, 78, 1197-1205. [Google Scholar] [CrossRef] [PubMed]
[35] Cote, A.T., Phillips, A.A., Harris, K.C., Sandor, G.G.S., Panagiotopoulos, C. and Devlin, A.M. (2015) Obesity and Arterial Stiffness in Children: Systematic Review and Meta-Analysis. Arteriosclerosis, Thrombosis, and Vascular Biology, 35, 1038-1044. [Google Scholar] [CrossRef] [PubMed]
[36] Guerrero-Romero, F., Simental-Mendía, L.E., González-Ortiz, M., Martínez-Abundis, E., Ramos-Zavala, M.G., Hernández-González, S.O., et al. (2010) The Product of Triglycerides and Glucose, a Simple Measure of Insulin Sensitivity. Comparison with the Euglycemic-Hyperinsulinemic Clamp. The Journal of Clinical Endocrinology & Metabolism, 95, 3347-3351. [Google Scholar] [CrossRef] [PubMed]
[37] Liang, S., Wang, C., Zhang, J., Liu, Z., Bai, Y., Chen, Z., et al. (2023) Triglyceride-Glucose Index and Coronary Artery Disease: A Systematic Review and Meta-Analysis of Risk, Severity, and Prognosis. Cardiovascular Diabetology, 22, Article No 170. [Google Scholar] [CrossRef] [PubMed]
[38] Vasques, A.C.J., Novaes, F.S., de Oliveira, M.d.S., Matos Souza, J.R., Yamanaka, A., Pareja, J.C., et al. (2011) Tyg Index Performs Better than HOMA in a Brazilian Population: A Hyperglycemic Clamp Validated Study. Diabetes Research and Clinical Practice, 93, e98-e100. [Google Scholar] [CrossRef] [PubMed]
[39] Tao, L., Xu, J., Wang, T., Hua, F. and Li, J. (2022) Triglyceride-Glucose Index as a Marker in Cardiovascular Diseases: Landscape and Limitations. Cardiovascular Diabetology, 21, Article No 68. [Google Scholar] [CrossRef] [PubMed]
[40] Selig, J.I., Ouwens, D.M., Raschke, S., Thoresen, G.H., Fischer, J.W., Lichtenberg, A., et al. (2019) Impact of Hyperinsulinemia and Hyperglycemia on Valvular Interstitial Cells—A Link between Aortic Heart Valve Degeneration and Type 2 Diabetes. Biochimica et Biophysica Acta (BBA)-Molecular Basis of Disease, 1865, 2526-2537. [Google Scholar] [CrossRef] [PubMed]
[41] Scatena, M., Jackson, M.F., Speer, M.Y., Leaf, E.M., Wallingford, M.C. and Giachelli, C.M. (2018) Increased Calcific Aortic Valve Disease in Response to a Diabetogenic, Procalcific Diet in the Ldlr-/- Apob100/100 Mouse Model. Cardiovascular Pathology, 34, 28-37. [Google Scholar] [CrossRef] [PubMed]
[42] Zhang, L., Chen, S., Deng, A., Liu, X., Liang, Y., Shao, X., et al. (2015) Association between Lipid Ratios and Insulin Resistance in a Chinese Population. PLOS ONE, 10, e0116110. [Google Scholar] [CrossRef] [PubMed]
[43] Chen, M., Meng, X., Han, Y., Yan, J., Xiao, C. and Qian, L. (2022) Profile of Crosstalk between Glucose and Lipid Metabolic Disturbance and Diabetic Cardiomyopathy: Inflammation and Oxidative Stress. Frontiers in Endocrinology, 13, Article 983713. [Google Scholar] [CrossRef] [PubMed]
[44] Criqui, M.H. and Golomb, B.A. (1998) Epidemiologic Aspects of Lipid Abnormalities. The American Journal of Medicine, 105, 48S-57S. [Google Scholar] [CrossRef] [PubMed]
[45] Imtiaz, F., Shafique, K., Mirza, S., Ayoob, Z., Vart, P. and Rao, S. (2012) Neutrophil Lymphocyte Ratio as a Measure of Systemic Inflammation in Prevalent Chronic Diseases in Asian Population. International Archives of Medicine, 5, Article No. 2. [Google Scholar] [CrossRef] [PubMed]
[46] Zahorec, R. (2021) Neutrophil-to-Lymphocyte Ratio, Past, Present and Future Perspectives. Bratislava Medical Journal, 122, 474-488. [Google Scholar] [CrossRef] [PubMed]
[47] Liu, Z., Liu, J., Wang, W., An, X., Luo, L., Yu, D., et al. (2023) Epigenetic Modification in Diabetic Kidney Disease. Frontiers in Endocrinology, 14, Article 1133970. [Google Scholar] [CrossRef] [PubMed]
[48] Einwoegerer, C.F. and Domingueti, C.P. (2018) Association between Increased Levels of Cystatin C and the Development of Cardiovascular Events or Mortality: A Systematic Review and Meta-analysis. Arquivos Brasileiros de Cardiologia, 111, 796-807. [Google Scholar] [CrossRef] [PubMed]
[49] Almén, M.S., Björk, J., Nyman, U., Lindström, V., Jonsson, M., Abrahamson, M., et al. (2019) Shrunken Pore Syndrome Is Associated with Increased Levels of Atherosclerosis-Promoting Proteins. Kidney International Reports, 4, 67-79. [Google Scholar] [CrossRef] [PubMed]
[50] Xhakollari, L., Jujic, A., Molvin, J., Nilsson, P., Holm, H., Bachus, E., et al. (2021) Proteins Linked to Atherosclerosis and Cell Proliferation Are Associated with the Shrunken Pore Syndrome in Heart Failure Patients. PROTEOMICS—Clinical Applications, 15, e2000089. [Google Scholar] [CrossRef] [PubMed]
[51] Hutcheson, J.D. and Goettsch, C. (2023) Cardiovascular Calcification Heterogeneity in Chronic Kidney Disease. Circulation Research, 132, 993-1012. [Google Scholar] [CrossRef] [PubMed]
[52] Ternacle, J., Côté, N., Krapf, L., Nguyen, A., Clavel, M. and Pibarot, P. (2019) Chronic Kidney Disease and the Pathophysiology of Valvular Heart Disease. Canadian Journal of Cardiology, 35, 1195-1207. [Google Scholar] [CrossRef] [PubMed]
[53] The Global Burden of Metabolic Risk Factors for Chronic Diseases Collaboration (2014) Cardiovascular Disease, Chronic Kidney Disease, and Diabetes Mortality Burden of Cardiometabolic Risk Factors from 1980 to 2010: A Comparative Risk Assessment. The Lancet Diabetes & Endocrinology, 2, 634-647. [Google Scholar] [CrossRef] 
[54] Park, C.S., Han, K. and Kim, H. (2022) Response to Comment on Park Et Al. U-Shaped Associations between Body Weight Changes and Major Cardiovascular Events in Type 2 Diabetes Mellitus: A Longitudinal Follow-Up Study of a Nationwide Cohort of over 1.5 Million. Diabetes Care 2022; 45: 1239-1246. Diabetes Care, 45, e188-e189. [Google Scholar] [CrossRef] [PubMed]

为你推荐